Inglewood — Inglewood, California

Inglewood is a clinical research site located in Inglewood, California, United States 90301.

Crixeo Clinical Trials Trust Score: 13/100 (FAILING). This profile has not yet been claimed by the site owner.

Inglewood has participated in 3 clinical trials with 1 currently active.

Therapeutic areas: Open-angle Glaucoma, Post Surgical Ocular Inflammation, Uterine Fibroids.

Sponsors: Alcon Research, Tarsier Pharma, Sumitomo Pharma Switzerland GmbH.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Inglewood

Browse all research sites in California · View every site in Inglewood

• Daniel Freeman Hospital
• Daniel Freeman Memorial Hospital
• Cancer Care Consultants Medical Associates at Daniel Freeman Memorial Hospital
• Centinela Hospital
• Centinela Freeman Memorial Hospital
• Centinela Hospital Medical Center
• United Medical Research Institute
• 310 Clinical Research
• Research Site
• Novo Nordisk Investigational Site
• Axon Clinical Research
• Chrishard Medical Group

Sponsor Feasibility Report

Trust Score: 13/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Inglewood?

Inglewood has a Crixeo Trust Score of 13/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Inglewood conducted?

Inglewood has 3 clinical trials on record, with 1 currently active. Their work covers Open-angle Glaucoma, Post Surgical Ocular Inflammation, Uterine Fibroids.

Is Inglewood accredited by Crixeo Clinical Trials?

Inglewood has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Inglewood?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.